| 321988 |
NEURO-ONCOLOGY |
METB-12. METABOLIC RE-PROGRAMING MEDIATES BIDIRECTIONAL SHIFT BETWEEN TRANSCRIPTIONAL SUBCLASSES AND DRIVES TUMOR HETEROGENEITY |
2017-11-01 |
10.1093/neuonc/nox168.536 |
Heiland Dieter Henrik, Gaebelein Annette, Borries Melanie, Wörner Jakob, Carro Maria Stella, Weber Stefan, Mader Irina, Schnell Oliver |
| 321987 |
BMJ OPEN |
Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison |
2017-11-01 |
10.1136/bmjopen-2017-017387 |
Roussakow Sergey V |
| 321986 |
NEURO-ONCOLOGY |
NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101 |
2017-11-01 |
10.1093/neuonc/nox168.647 |
Nowosielski Martha, Gorlia Thierry, Bromberg Jacolien, Sahm Felix, Harting Inga, Kickingereder Philipp, Brandes Alba, Taphoorn Martin J B, Taal Walter, Domont Julien, Idbaih Ahmed, Campone Mario, Clement Paul, Weller Michael, Fabbro Michel, Dubois Francois, Platten Michael, Golfinopoulos Vassilis, Bendszus Martin, van den Bent Martin, Wick Wolfgang |
| 321985 |
NEURO-ONCOLOGY |
ATIM-23. PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM |
2017-11-01 |
10.1093/neuonc/nox168.118 |
Lim Michael, Ye Xiaobu, Nabors Burt, Piotrowski Anna F, Fisher Joy, Desideri Serena, Sims Megan, Wen Patrick, Grossman Stuart A |
| 321984 |
NEURO-ONCOLOGY |
PATH-05. ALDH1A3, THE CRITICAL ALDEHYDE DEHYDROGENASE ISOFORM, DETERMINES GLIOMA STEM-LIKE CELL MESENCHYMAL IDENTITY AND POOR CLINICAL OUTCOME |
2017-11-01 |
10.1093/neuonc/nox168.696 |
Li Guanzhang, Zhang Wei |
| 321983 |
NEURO-ONCOLOGY |
NCMP-06. NEUROLOGICAL OUTCOME IN PEDIATRIC CERVICOMEDULLARY TUMORS |
2017-11-01 |
10.1093/neuonc/nox168.557 |
Sadighi Zsila, Curtis Elizabeth, Zabrowski Jennifer, Onar-Thomas Arzu, Khan Raja, Gajjar Amar, Boop Frederick, Klimo Paul, Broniscer Alberto |
| 321982 |
BMJ OPEN |
Norwegian trends in numbers of lower extremity revascularisations and amputations including regional trends in endovascular treatments for peripheral arterial disease: a retrospective cross-sectional registry study from 2001 to 2014 |
2017-11-01 |
10.1136/bmjopen-2017-016210 |
Wendt Kjersti, Kristiansen Ronny, Krohg-Sørensen Kirsten, Gregersen Fredrik Alexander, Fosse Erik |
| 321981 |
ONCOTARGETS AND THERAPY |
In vitro study on anti-cancer properties of genistein in tongue cancer |
2017-11-01 |
10.2147/ott.s133632 |
ARDITO FATIMA, PELLEGRINO MARIO ROBERTO, PERRONE DONATELLA, TROIANO GIUSEPPE, COCCO ARMANDO, Lo Muzio LORENZO |
| 321980 |
NEURO-ONCOLOGY |
CMET-46. EXPRESSION OF HYDROGEN SULFIDE (H2S) PRODUCING ENZYMES IN METASTATIC BRAIN TUMORS |
2017-11-01 |
10.1093/neuonc/nox168.192 |
Lechpammer Mirna, Shahlaie Kiarash, Girgis Fady, Gonzales Hilary, Bishop John, Nudler Evgeny, Zagzag David |
| 321979 |
NEURO-ONCOLOGY |
ACTR-56. A 2-PART SAFETY AND EXPLORATORY EFFICACY RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A 1:1 RATIO OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL (CBD:THC) PLUS DOSE-INTENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME |
2017-11-01 |
10.1093/neuonc/nox168.047 |
Short Susan C, Little Christian, The Cannabinoid in Recurrent Glioma Study Group |
